BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1223 related articles for article (PubMed ID: 23897323)

  • 1. Antifibrinolytics (lysine analogues) for the prevention of bleeding in patients with haematological disorders.
    Wardrop D; Estcourt LJ; Brunskill SJ; Doree C; Trivella M; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Jul; (7):CD009733. PubMed ID: 23897323
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antifibrinolytics (lysine analogues) for the prevention of bleeding in people with haematological disorders.
    Estcourt LJ; Desborough M; Brunskill SJ; Doree C; Hopewell S; Murphy MF; Stanworth SJ
    Cochrane Database Syst Rev; 2016 Mar; 3(3):CD009733. PubMed ID: 26978005
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prophylactic platelet transfusion for prevention of bleeding in patients with haematological disorders after chemotherapy and stem cell transplantation.
    Estcourt L; Stanworth S; Doree C; Hopewell S; Murphy MF; Tinmouth A; Heddle N
    Cochrane Database Syst Rev; 2012 May; (5):CD004269. PubMed ID: 22592695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A therapeutic-only versus prophylactic platelet transfusion strategy for preventing bleeding in patients with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Crighton GL; Estcourt LJ; Wood EM; Trivella M; Doree C; Stanworth S
    Cochrane Database Syst Rev; 2015 Sep; 2015(9):CD010981. PubMed ID: 26422767
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of different platelet count thresholds to guide administration of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth SJ; Doree C; Hopewell S; Trivella M; Murphy MF
    Cochrane Database Syst Rev; 2015 Nov; 2015(11):CD010983. PubMed ID: 26576687
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacological interventions for the prevention of bleeding in people undergoing elective hip or knee surgery: a systematic review and network meta-analysis.
    Gibbs VN; Champaneria R; Sandercock J; Welton NJ; Geneen LJ; Brunskill SJ; Dorée C; Kimber C; Palmer AJ; Estcourt LJ
    Cochrane Database Syst Rev; 2024 Jan; 1(1):CD013295. PubMed ID: 38226724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Jan; (1):CD001886. PubMed ID: 21249650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2015 Dec; (12):CD011385. PubMed ID: 26704192
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Different doses of prophylactic platelet transfusion for preventing bleeding in people with haematological disorders after myelosuppressive chemotherapy or stem cell transplantation.
    Estcourt LJ; Stanworth S; Doree C; Trivella M; Hopewell S; Blanco P; Murphy MF
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD010984. PubMed ID: 26505729
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review.
    Desborough M; Hadjinicolaou AV; Chaimani A; Trivella M; Vyas P; Doree C; Hopewell S; Stanworth SJ; Estcourt LJ
    Cochrane Database Syst Rev; 2016 Oct; 10(10):CD012055. PubMed ID: 27797129
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; McClelland B; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2007 Oct; (4):CD001886. PubMed ID: 17943760
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Alternatives, and adjuncts, to prophylactic platelet transfusion for people with haematological malignancies undergoing intensive chemotherapy or stem cell transplantation.
    Desborough M; Estcourt LJ; Doree C; Trivella M; Hopewell S; Stanworth SJ; Murphy MF
    Cochrane Database Syst Rev; 2016 Aug; 2016(8):CD010982. PubMed ID: 27548292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Carless PA; Moxey AJ; O'Connell D; Stokes BJ; Fergusson DA; Ker K
    Cochrane Database Syst Rev; 2011 Mar; 2011(3):CD001886. PubMed ID: 21412876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pathogen-reduced platelets for the prevention of bleeding.
    Butler C; Doree C; Estcourt LJ; Trivella M; Hopewell S; Brunskill SJ; Stanworth S; Murphy MF
    Cochrane Database Syst Rev; 2013 Mar; (3):CD009072. PubMed ID: 23543569
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antifibrinolytic therapy for preventing oral bleeding in patients with haemophilia or Von Willebrand disease undergoing minor oral surgery or dental extractions.
    van Galen KP; Engelen ET; Mauser-Bunschoten EP; van Es RJ; Schutgens RE
    Cochrane Database Syst Rev; 2019 Apr; 4(4):CD011385. PubMed ID: 31002742
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-fibrinolytic use for minimising perioperative allogeneic blood transfusion.
    Henry DA; Moxey AJ; Carless PA; O'Connell D; McClelland B; Henderson KM; Sly K; Laupacis A; Fergusson D
    Cochrane Database Syst Rev; 2001; (1):CD001886. PubMed ID: 11279735
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prophylactic platelet transfusion for haemorrhage after chemotherapy and stem cell transplantation.
    Stanworth SJ; Hyde C; Heddle N; Rebulla P; Brunskill S; Murphy MF
    Cochrane Database Syst Rev; 2004 Oct; (4):CD004269. PubMed ID: 15495093
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antifibrinolytic drugs for treating primary postpartum haemorrhage.
    Shakur H; Beaumont D; Pavord S; Gayet-Ageron A; Ker K; Mousa HA
    Cochrane Database Syst Rev; 2018 Feb; 2(2):CD012964. PubMed ID: 29462500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficacy of antifibrinolytic agents on surgical bleeding and transfusion requirements in spine surgery: a meta-analysis.
    Li G; Sun TW; Luo G; Zhang C
    Eur Spine J; 2017 Jan; 26(1):140-154. PubMed ID: 27671279
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antifibrinolytic therapy for preventing oral bleeding in people on anticoagulants undergoing minor oral surgery or dental extractions.
    Engelen ET; Schutgens RE; Mauser-Bunschoten EP; van Es RJ; van Galen KP
    Cochrane Database Syst Rev; 2018 Jul; 7(7):CD012293. PubMed ID: 29963686
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 62.